Literature DB >> 28596183

Leptogenic effects of NAPE require activity of NAPE-hydrolyzing phospholipase D.

Zhongyi Chen1, Yongqin Zhang1, Lilu Guo1, Noura Dosoky1, Lorenzo de Ferra2, Scott Peters3, Kevin D Niswender4, Sean S Davies5.   

Abstract

Food intake induces synthesis of N-acylphosphatidylethanolamines (NAPEs) in the intestinal tract. While NAPEs exert leptin-like (leptogenic) effects, including reduced weight gain and food intake, the mechanisms by which NAPEs induce these leptogenic effects remain unclear. One key question is whether intestinal NAPEs act directly on cognate receptors or first require conversion to N-acylethanolamides (NAEs) by NAPE-hydrolyzing phospholipase D (NAPE-PLD). Previous studies using Nape-pld-/- mice were equivocal because intraperitoneal injection of NAPEs led to nonspecific aversive effects. To avoid the aversive effects of injection, we delivered NAPEs and NAEs intestinally using gut bacteria synthesizing these compounds. Unlike in wild-type mice, increasing intestinal levels of NAPE using NAPE-synthesizing bacteria in Nape-pld-/- mice failed to reduce food intake and weight gain or alter gene expression. In contrast, increasing intestinal NAE levels in Nape-pld-/- mice using NAE-synthesizing bacteria induced all of these effects. These NAE-synthesizing bacteria also markedly increased NAE levels and decreased inflammatory gene expression in omental adipose tissue. These results demonstrate that intestinal NAPEs require conversion to NAEs by the action of NAPE-PLD to exert their various leptogenic effects, so that the reduced intestinal NAPE-PLD activity found in obese subjects may directly contribute to excess food intake and obesity.
Copyright © 2017 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  N-acylethanolamides; N-acylphosphatidylethanolamine,; adipose; diet effects/lipid metabolism; feeding behavior; liver; obesity; phosphatidylethanolamine; phospholipases

Mesh:

Substances:

Year:  2017        PMID: 28596183      PMCID: PMC5538284          DOI: 10.1194/jlr.M076513

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  57 in total

1.  Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice.

Authors:  A M McKillop; B M Moran; Y H A Abdel-Wahab; P R Flatt
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

2.  A liquid chromatography-tandem mass spectrometry method for measurement of N-modified phosphatidylethanolamines.

Authors:  Lilu Guo; Venkataraman Amarnath; Sean S Davies
Journal:  Anal Biochem       Date:  2010-06-19       Impact factor: 3.365

3.  Feeding-induced oleoylethanolamide mobilization is disrupted in the gut of diet-induced obese rodents.

Authors:  Miki Igarashi; Nicholas V DiPatrizio; Vidya Narayanaswami; Daniele Piomelli
Journal:  Biochim Biophys Acta       Date:  2015-05-27

4.  The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin.

Authors:  Silvana Gaetani; Jin Fu; Tommaso Cassano; Pasqua Dipasquale; Adele Romano; Laura Righetti; Silvia Cianci; Leonardo Laconca; Elisa Giannini; Sergio Scaccianoce; Jérôme Mairesse; Vincenzo Cuomo; Daniele Piomelli
Journal:  J Neurosci       Date:  2010-06-16       Impact factor: 6.167

5.  Food intake regulates oleoylethanolamide formation and degradation in the proximal small intestine.

Authors:  Jin Fu; Giuseppe Astarita; Silvana Gaetani; Janet Kim; Benjamin F Cravatt; Ken Mackie; Daniele Piomelli
Journal:  J Biol Chem       Date:  2006-11-22       Impact factor: 5.157

6.  An anorexic lipid mediator regulated by feeding.

Authors:  F Rodríguez de Fonseca; M Navarro; R Gómez; L Escuredo; F Nava; J Fu; E Murillo-Rodríguez; A Giuffrida; J LoVerme; S Gaetani; S Kathuria; C Gall; D Piomelli
Journal:  Nature       Date:  2001-11-08       Impact factor: 49.962

7.  Activation of GPR119 by fatty acid agonists augments insulin release from clonal β-cells and isolated pancreatic islets and improves glucose tolerance in mice.

Authors:  Brian M Moran; Yasser H A Abdel-Wahab; Peter R Flatt; Aine M McKillop
Journal:  Biol Chem       Date:  2014-04       Impact factor: 3.915

8.  Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity.

Authors:  Zhongyi Chen; Lilu Guo; Yongqin Zhang; Rosemary L Walzem; Julie S Pendergast; Richard L Printz; Lindsey C Morris; Elena Matafonova; Xavier Stien; Li Kang; Denis Coulon; Owen P McGuinness; Kevin D Niswender; Sean S Davies
Journal:  J Clin Invest       Date:  2014-06-24       Impact factor: 14.808

Review 9.  Biology of endocannabinoid synthesis system.

Authors:  Jun Wang; Natsuo Ueda
Journal:  Prostaglandins Other Lipid Mediat       Date:  2008-12-14       Impact factor: 3.072

10.  Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine.

Authors:  Andreas Artmann; Gitte Petersen; Lars I Hellgren; Julie Boberg; Christian Skonberg; Christine Nellemann; Steen Honoré Hansen; Harald S Hansen
Journal:  Biochim Biophys Acta       Date:  2008-02-12
View more
  6 in total

1.  Symmetrically substituted dichlorophenes inhibit N-acyl-phosphatidylethanolamine phospholipase D.

Authors:  Geetika Aggarwal; Jonah E Zarrow; Zahra Mashhadi; C Robb Flynn; Paige Vinson; C David Weaver; Sean S Davies
Journal:  J Biol Chem       Date:  2020-04-13       Impact factor: 5.157

2.  Two-week administration of engineered Escherichia coli establishes persistent resistance to diet-induced obesity even without antibiotic pre-treatment.

Authors:  Noura S Dosoky; Zhongyi Chen; Yan Guo; Clara McMillan; C Robb Flynn; Sean S Davies
Journal:  Appl Microbiol Biotechnol       Date:  2019-06-15       Impact factor: 4.813

3.  Administration of N-Acyl-Phosphatidylethanolamine Expressing Bacteria to Low Density Lipoprotein Receptor-/- Mice Improves Indices of Cardiometabolic Disease.

Authors:  Linda S May-Zhang; Zhongyi Chen; Noura S Dosoky; Patricia G Yancey; Kelli L Boyd; Alyssa H Hasty; MacRae F Linton; Sean S Davies
Journal:  Sci Rep       Date:  2019-01-23       Impact factor: 4.379

Review 4.  Mutual Links between the Endocannabinoidome and the Gut Microbiome, with Special Reference to Companion Animals: A Nutritional Viewpoint.

Authors:  Aniello Schiano Moriello; Vincenzo Di Marzo; Stefania Petrosino
Journal:  Animals (Basel)       Date:  2022-01-31       Impact factor: 2.752

5.  Selective measurement of NAPE-PLD activity via a PLA1/2-resistant fluorogenic N-acyl-phosphatidylethanolamine analog.

Authors:  Jonah E Zarrow; Jianhua Tian; Brendan Dutter; Kwangho Kim; Amanda C Doran; Gary A Sulikowski; Sean S Davies
Journal:  J Lipid Res       Date:  2021-11-26       Impact factor: 5.922

6.  Endocannabinoids, endocannabinoid-like molecules and their precursors in human small intestinal lumen and plasma: does diet affect them?

Authors:  Silvia Tagliamonte; Chris I R Gill; L Kirsty Pourshahidi; Mary M Slevin; Ruth K Price; Rosalia Ferracane; Roger Lawther; Gloria O'Connor; Paola Vitaglione
Journal:  Eur J Nutr       Date:  2020-10-26       Impact factor: 5.614

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.